Table 2.

Pre-adjusted prevalence vs adjusted prevalence for primary malignant brain tumors in the US, 2010

Age	Counts	Adjusted Counts	Prevalencea	Adjusted Prevalencea
Child (0–14 y)	13,657	13,657	22.31	22.31
00-04	2,319	2,319	11.49	11.49
05-09	4,838	4,838	23.79	23.79
10–14	6,499	6,499	31.43	31.43
AYA (15–39 y)	31,299	50,902	29.81	48.49
15–19	6,971	7,759	31.72	35.30
20–24	6,185	9,410	29.31	51.98
25–29	5,930	10,890	28.05	51.50
30-24	5,983	11,173	29.81	55.67
35–39	6,229	11,671	31.03	58.13
Adult (40+ y)	58,678	82,661	33.80	58.71
40–44	7,065	12,272	40.99	57.75
45–49	8,423	13,241	37.21	58.50
50–54	8,686	12,710	38.86	56.87
55–59	8,407	11,761	42.47	59.42
60–64	7,869	10,493	46.32	61.76
65–69	6,134	7,777	48.99	62.11
70–74	4,694	5,626	50.28	60.26
75–79	3,599	4,181	49.18	57.12
80–84	2,573	3,007	44.68	52.22
85+	1,228	1,594	22.16	28.75
All	103,634	147,220	33.50	47.59

^aProportions are per 100000 population.